SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-068163
Filing Date
2009-03-31
Accepted
2009-03-30 21:15:42
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K d10k.htm 10-K 765307
2 AMENDMENT TO EMPLOYMENT LETTER AGREEMENT WITH RONALD PRENTKI, PRESIDENT AND CEO dex10v.htm EX-10.V 15616
3 AMENDMENT TO MANAGEMENT RETENTION AGREEMENT - DR. JOHN BARR dex10w.htm EX-10.W 13829
4 EMPLOYMENT LETTER AGREEMENT WITH JOHN B. WHELAN, CFO dex10x.htm EX-10.X 6724
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2011
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-15(E) dex311.htm EX-31.1 8479
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-15(E) dex312.htm EX-31.2 8589
8 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 5659
9 GRAPHIC g26805g27o95.jpg GRAPHIC 39827
10 GRAPHIC g26805g75c29.jpg GRAPHIC 25231
  Complete submission text file 0001193125-09-068163.txt   917670
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 09715751
SIC: 2834 Pharmaceutical Preparations